Marcel Maier
8Patents
3h-index
11Co-inventors
50Inventor score
Filing activity: Sep 1, 2008 → Jun 4, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9283271B2 | Human anti-SOD1 antibodies | Physics | 3 | Active |
| US9370531B2 | Method of providing patient specific immune response in amyloidoses and protein aggregation disorders | Emerging Cross-Sectional Technologies | 3 | Active |
| US10874725B2 | Method of providing patient specific immune response in amyloidoses and protein aggregation disorders | Emerging Cross-Sectional Technologies | 3 | Active |
| US10344097B2 | Human anti-SOD1 antibodies | Physics | 1 | Active |
| US10556946B2 | Human derived anti-Huntingtin (HTT) antibodies and uses thereof | Physics | 1 | Active |
| US11352441B2 | Human anti-SOD1 antibodies | Physics | 0 | Active |
| US11401325B2 | Human-derived anti-huntingtin (HTT) antibodies and uses thereof | Physics | 0 | Active |
| US11870307B2 | Method for increasing the efficiency of an energy transfer device, energy transfer device, and use of an electrically conductive material | Electricity | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.